PRONZO, VIRGINIA
 Distribuzione geografica
Continente #
NA - Nord America 147
AS - Asia 71
EU - Europa 60
SA - Sud America 18
AF - Africa 5
Totale 301
Nazione #
US - Stati Uniti d'America 141
SG - Singapore 36
RU - Federazione Russa 18
BR - Brasile 14
HK - Hong Kong 12
SE - Svezia 11
DE - Germania 10
CN - Cina 9
IT - Italia 6
CA - Canada 5
VN - Vietnam 5
CI - Costa d'Avorio 4
AR - Argentina 3
GB - Regno Unito 3
AT - Austria 2
BD - Bangladesh 2
BE - Belgio 2
FI - Finlandia 2
FR - Francia 2
TR - Turchia 2
AM - Armenia 1
EE - Estonia 1
ES - Italia 1
ID - Indonesia 1
JP - Giappone 1
LT - Lituania 1
NL - Olanda 1
PH - Filippine 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 301
Città #
Ashburn 27
Singapore 19
Chandler 15
Fairfield 12
Hong Kong 12
Nyköping 7
New York 6
Woodbridge 6
Beijing 5
Cambridge 5
Munich 5
Seattle 5
Abidjan 4
Dallas 4
Frankfurt am Main 4
Buffalo 3
Chicago 3
Houston 3
Stockholm 3
Vancouver 3
Wilmington 3
Ann Arbor 2
Brooklyn 2
Brussels 2
Inglewood 2
Lawrence 2
Los Angeles 2
Modugno 2
São Paulo 2
Turku 2
Vienna 2
Amsterdam 1
Arequito 1
Arraial do Cabo 1
Atlanta 1
Bari 1
Barra de Guabiraba 1
Boca Raton 1
Boston 1
Cachoeirinha 1
Calgary 1
Campinas 1
Canoas 1
Chaguanas 1
Da Nang 1
Dayton 1
Denver 1
Des Moines 1
Dhaka 1
El Mourouj 1
Falkenstein 1
Ferraz de Vasconcelos 1
González Catán 1
Hanoi 1
Hope Mills 1
Hwang Chow 1
Istanbul 1
Izmir 1
Jakarta 1
London 1
Luís Antônio 1
Merthyr Tydfil 1
Mogi Guaçu 1
Nanning 1
Nova Viçosa 1
Paramaribo 1
Perm 1
Pescara 1
Princeton 1
Providence 1
Quảng Ngãi 1
Rio Grande 1
Roxbury 1
Salt Lake City 1
San Juan 1
Serra 1
São José dos Campos 1
Tam Bình 1
Tashkent 1
Tokyo 1
Topeka 1
Toronto 1
Tây Ninh 1
Xi'an 1
Yerevan 1
Totale 228
Nome #
Severe COVID-19 by SARS-CoV-2 lineage B.1.1.7 in vaccinated solid-organ transplant recipients: New preventive strategies needed to protect immunocompromised patients 103
Effective and safe off-label use of caplacizumab treatment in a middle-aged obese male 102
Kinetics of humoral immune response and severity of infection after three doses of SARS-CoV-2 mRNA vaccine in a large cohort of kidney transplant recipients 68
Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort study 41
Totale 314
Categoria #
all - tutte 1.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.605


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 26 1 2 0 2 0
2021/202218 3 1 0 2 0 2 0 3 1 1 3 2
2022/202335 3 6 2 0 5 4 0 6 6 1 2 0
2023/202421 1 4 0 4 4 8 0 0 0 0 0 0
2024/2025101 3 1 1 7 2 13 10 15 4 8 11 26
2025/2026108 29 11 14 15 33 6 0 0 0 0 0 0
Totale 314